期刊
EUROPEAN RESPIRATORY JOURNAL
卷 53, 期 1, 页码 -出版社
EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/13993003.01887-2018
关键词
-
资金
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL014985, R01HL074186, R01HL122887, P01HL108797, R01HL138473] Funding Source: NIH RePORTER
- NHLBI NIH HHS [R01 HL122887, P01 HL014985, R01 HL074186, R01 HL138473, P01 HL108797] Funding Source: Medline
Clinical and translational research has played a major role in advancing our understanding of pulmonary hypertension (PH), including pulmonary arterial hypertension and other forms of PH with severe vascular remodelling (e. g. chronic thromboembolic PH and pulmonary veno- occlusive disease). However, PH remains an incurable condition with a high mortality rate, underscoring the need for a better transfer of novel scientific knowledge into healthcare interventions. Herein, we review recent findings in pathology (with the questioning of the strict morphological categorisation of various forms of PH into pre- or post- capillary involvement of pulmonary vessels) and cellular mechanisms contributing to the onset and progression of pulmonary vascular remodelling associated with various forms of PH. We also discuss ways to improve management and to support and optimise drug development in this research field.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据